CD44-Targeted Magnetic Nanoparticles Kill Head And Neck Squamous Cell Carcinoma Stem Cells In An Alternating Magnetic Field

References

• Chen L, Hu CS, Chen XZ, et al. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2012;13(2):163–171. doi:10.1016/S1470-2045(11)70320-522154591
   PubMed Web of Science ®Google Scholar
• Chua DT, Sham JS, Au GK, Choy D. Concomitant chemoirradiation for stage III-IV nasopharyngeal carcinoma in Chinese patients: results of a matched cohort analysis. Int J Radiat Oncol Biol Phys. 2002;53(2):334–343. doi:10.1016/s0360-3016(02)02710-412023137
   PubMedGoogle Scholar
• Krishnamurthy S, Nör JE. Head and neck cancer stem cells. J Dent Res. 2012;91(4):334–340. doi:10.1177/002203451142339321933937
   PubMedGoogle Scholar
• Sayed SI, Dwivedi RC, Katna R, et al. Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer. Oral Oncol. 2011;47(4):237–243. doi:10.1016/j.oraloncology.2011.02.00921382740
   PubMedGoogle Scholar
• Krishnamurthy S, Dong Z, Vodopyanov D, et al. Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. Cancer Res. 2010;70(23):9969–9978. doi:10.1158/0008-5472.CAN-10-171221098716
   PubMedGoogle Scholar
• Zhao Y, Bao Q, Schwarz B, et al. Stem cell-like side populations in esophageal cancer: a source of chemotherapy resistance and metastases. Stem Cells Dev. 2014;23(2):180–192. doi:10.1089/scd.2013.010324021093
   PubMedGoogle Scholar
• Fang DD, Cao J, Jani JP, et al. Combined gemcitabine and CHK1 inhibitor treatment induces apoptosis resistance in cancer stem cell-like cells enriched with tumor spheroids from a non-small cell lung cancer cell line. Front Med-Prc. 2013;7(4):462–476. doi:10.1007/s11684-013-0270-6
   PubMed Web of Science ®Google Scholar
• Campos MS, Neiva KG, Meyers KA, Krishnamurthy S, Nör JE. Endothelial derived factors inhibit anoikis of head and neck cancer stem cells. Oral Oncol. 2012;48(1):26–32. doi:10.1016/j.oraloncology.2011.09.01022014666
   PubMedGoogle Scholar
• Burke AR, Singh RN, Carroll DL, et al. The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy. Biomaterials. 2012;33(10):2961–2970. doi:10.1016/j.biomaterials.2011.12.05222245557
   PubMed Web of Science ®Google Scholar
• Kobayashi T. Cancer hyperthermia using magnetic nanoparticles. Biotechnol J. 2011;6(11):1342–1347. doi:10.1002/biot.20110004522069094
   PubMed Web of Science ®Google Scholar
• Sadhukha T, Niu L, Wiedmann TS, Panyam J. Effective elimination of cancer stem cells by magnetic hyperthermia. Mol Pharmaceut. 2013;10(4):1432–1441. doi:10.1021/mp400015b
   PubMed Web of Science ®Google Scholar
• Kaseb HO, Fohrer-Ting H, Lewis DW, Lagasse E, Gollin SM. Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas. Exp Cell Res. 2016;348(1):75–86. doi:10.1016/j.yexcr.2016.09.00327619333
   PubMedGoogle Scholar
• Bourguignon LYW, Earle C, Shiina M. Activation of matrix hyaluronan-mediated CD44 signaling, epigenetic regulation and chemoresistance in head and neck cancer stem cells. Int J Mol Sci. 2017;18(9):1849. doi:10.3390/ijms18091849
   PubMed Web of Science ®Google Scholar
• Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells. Cancer Res. 2007;67(3):1030–1037. doi:10.1158/0008-5472.CAN-06-203017283135
   PubMed Web of Science ®Google Scholar
• Prince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A. 2007;104(3):973–978. doi:10.1073/pnas.061011710417210912
   PubMed Web of Science ®Google Scholar
• Endo K, Terada T. Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival. J Hepatol. 2000;32(1):78–84. doi:10.1016/s0168-8278(00)80192-010673070
   PubMed Web of Science ®Google Scholar
• Okamoto A, Chikamatsu K, Sakakura K, Hatsushika K, Takahashi G, Masuyama K. Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. Oral Oncol. 2009;45(7):633–639. doi:10.1016/j.oraloncology.2008.10.00319027347
   PubMedGoogle Scholar
• Creixell M, Bohórquez AC, Torres-Lugo M, Rinaldi C. EGFR-targeted magnetic nanoparticle heaters kill cancer cells without a perceptible temperature rise. ACS Nano. 2011;5(9):7124–7129. doi:10.1021/nn201822b21838221
   PubMed Web of Science ®Google Scholar
• Shen Y, Wu C, Uyeda TQP, et al. Elongated nanoparticle aggregates in cancer cells for mechanical destruction with low frequency rotating magnetic field. Theranostics. 2017;7(6):1735–1748. doi:10.7150/thno.1835228529648
   PubMedGoogle Scholar
• Shevtsov MA, Nikolaev BP, Yakovleva LY, et al. Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION-EGF) for targeting brain tumors. Int J Nanomedicine. 2014;9:273–287. doi:10.2147/IJN.S5511824421639
   PubMed Web of Science ®Google Scholar
• Zhu LL, Zhang Z, Jiang HS, Chen H, Chen Y, Dai YT. Superparamagnetic iron oxide nanoparticle targeting of adipose tissue-derived stem cells in diabetes-associated erectile dysfunction. Asian J Androl. 2017;19(4):425–432. doi:10.4103/1008-682X.17953227157506
   PubMed Web of Science ®Google Scholar
• Lim YC, Oh S, Cha YY, Kim S, Jin X, Kim H. Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas. Oral Oncol. 2011;47(2):83–91. doi:10.1016/j.oraloncology.2010.11.01121167769
   PubMedGoogle Scholar
• Qiu X, Wang Z, Li Y, Miao Y, Ren Y, Luan Y. Characterization of sphere-forming cells with stem-like properties from the small cell lung cancer cell line H446. Cancer Lett. 2012;323(2):161–170. doi:10.1016/j.canlet.2012.04.00422521544
   PubMed Web of Science ®Google Scholar
• Fu T, Hsieh I, Cheng J, et al. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression. J Oral Pathol Med. 2016;45(2):89–95. doi:10.1111/jop.1233526211876
   PubMedGoogle Scholar
• Guo X, Li W, Luo L, et al. External magnetic field-enhanced chemo-photothermal combination tumor therapy via iron oxide nanoparticles. Acs Appl Mater Inter. 2017;9(19):16581–16593. doi:10.1021/acsami.6b16513
   PubMed Web of Science ®Google Scholar
• Creixell M, Herrera AP, Ayala V, et al. Preparation of epidermal growth factor (EGF) conjugated iron oxide nanoparticles and their internalization into colon cancer cells. J Magn Magn Mater. 2010;322(15):2244–2250. doi:10.1016/j.jmmm.2010.02.019
   Web of Science ®Google Scholar
• Kruse AM, Meenach SA, Anderson KW, Hilt JZ. Synthesis and characterization of CREKA-conjugated iron oxide nanoparticles for hyperthermia applications. Acta Biomater. 2014;10(6):2622–2629. doi:10.1016/j.actbio.2014.01.02524486913
   PubMed Web of Science ®Google Scholar
• Chen Q, Ke H, Dai Z, Liu Z. Nanoscale theranostics for physical stimulus-responsive cancer therapies. Biomaterials. 2015;73:214–230. doi:10.1016/j.biomaterials.2015.09.01826410788
   PubMed Web of Science ®Google Scholar
• Wust P, Hildebrandt B, Sreenivasa G, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol. 2002;3(8):487–497.12147435
   PubMed Web of Science ®Google Scholar
• Gioanni J, Fischel JL, Lambert JC, et al. Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. Eur J Cancer Clin Oncol. 1988;24(9):1445–1455.3181269
   PubMedGoogle Scholar
• Akbarzadeh M, Maroufi NF, Tazehkand AP, et al. Current approaches in identification and isolation of cancer stem cells. J Cell Physiol. 2019;234(9):14759–14772. doi:10.1002/jcp.28271
   PubMed Web of Science ®Google Scholar
• Shrivastava S, Steele R, Sowadski M, Crawford SE, Varvares M, Ray RB. Identification of molecular signature of head and neck cancer stem-like cells. Sci Rep-Uk. 2015;5(1).
   Google Scholar
• Setoguchi T, Taga T, Kondo T. Cancer stem cells persist in many cancer cell lines. Cell Cycle. 2004;3(4):414–415. doi:10.4161/cc.3.4.79915004528
   PubMedGoogle Scholar
• Zhang P, Zhang Y, Mao L, Zhang Z, Chen W. Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes. Cancer Lett. 2009;277(2):227–234. doi:10.1016/j.canlet.2008.12.01519185988
   PubMed Web of Science ®Google Scholar